top of page

Home
About
Technology
Products
R&D
Investors
News
Contact
More

Use tab to navigate through the menu items.

Influenza A/B Diagnostic Test Prototype Completed

Product News

6 Jan 2023

Gemina Labs completes influenza A/B diagnostic test prototype

Samire Essebiyea, Director

ABOUT Gemina Labs

We're an expanding company with an amazing piece of chemistry, innovative products and best-in-class R&D capabilities. Together, we can transform the in vitro diagnostics sector and possess drive and energy to make a positive difference in the medical, healthcare, wellness and occupational health sectors.

Our IP, business model, organisational culture and vision is attracting the attention of the diagnostics industry and a growing network of the world's best biochemists, healthcare professionals, academics and business leaders.

CONTACT

Technology:

info@geminalabs.com

Products:

info@geminalabs.com

R&D Services:

info@rapivd.com

Investors:

investor@geminalabs.com

Stay in touch

We send occasional product, company and technology updates. We won't bombard your inbox and you can unsubscribe at any time.

Thanks for submitting

© 2023 Gemina Labs

Disclaimers | Data & Privacy

bottom of page